Renal Cancer - Results from #5280

Clear Cell Renal Cell Carcinoma with Intratumoral Granulomatous Reaction: A Case Report and Review of the Literature March 24, 2017

Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents March 24, 2017

Comprehensive assessment of renal tumor complexity in a large percutaneous cryoablation cohort March 23, 2017

[Nephropathy in Patients Undergoing Cancer Drug Therapy - Platinum Derivatives(Cisplatin and Carboplatin)] March 23, 2017

The Role of High Dose Interleukin-2 in the Era of Targeted Therapy March 23, 2017

Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma March 22, 2017

Reproducibility and interobserver agreement of the R.E.N.A.L. nephrometry score: focus on imaging features March 22, 2017

Human mass balance study and metabolite profiling of (14)C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer March 21, 2017

Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions March 21, 2017

Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectives March 21, 2017

Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms March 21, 2017

Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study. March 21, 2017

Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study March 20, 2017

Overall survival of 1st-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study March 20, 2017

[Pulmonary metastasectomy in renal cell carcinoma] March 18, 2017

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial March 17, 2017

Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy March 16, 2017

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma March 16, 2017

Tumor-Infiltrating and Peripheral Blood T Cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma March 16, 2017

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma March 14, 2017

Page 265 of 456